143 related articles for article (PubMed ID: 20445534)
21. A clinical study of Japanese patients with ulcer induced by low-dose aspirin and other non-steroidal anti-inflammatory drugs.
Nakashima S; Arai S; Mizuno Y; Yoshino K; Ando S; Nakamura Y; Sugawara K; Koike M; Saito E; Naito M; Nakao M; Ito H; Hamaoka K; Rai F; Asakura Y; Akamatu M; Fujimori K; Inao M; Imai Y; Ota S; Fujiwara K; Shiibashi M
Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():60-6. PubMed ID: 15943849
[TBL] [Abstract][Full Text] [Related]
22. No modification of the beneficial effect of NSAIDs on colorectal cancer by CYP2C9 genotype.
Siemes C; Eijgelsheim M; Dieleman JP; van Schaik RH; Uitterlinden AG; van Duijn CM; Hofman A; Coebergh JW; Stricker BH; Visser LE
Neth J Med; 2009 Apr; 67(4):134-41. PubMed ID: 19581657
[TBL] [Abstract][Full Text] [Related]
23. The impact of research quality and study design on epidemiologic estimates of the effect of nonsteroidal anti-inflammatory drugs on upper gastrointestinal tract disease.
Bollini P; García Rodríguez LA; Pérez Gutthann S; Walker AM
Arch Intern Med; 1992 Jun; 152(6):1289-95. PubMed ID: 1534651
[TBL] [Abstract][Full Text] [Related]
24. Risk of upper gastrointestinal bleeding associated with use of low-dose aspirin.
Sørensen HT; Mellemkjaer L; Blot WJ; Nielsen GL; Steffensen FH; McLaughlin JK; Olsen JH
Am J Gastroenterol; 2000 Sep; 95(9):2218-24. PubMed ID: 11007221
[TBL] [Abstract][Full Text] [Related]
25. COX-2-selective inhibitors and the risk of upper gastrointestinal bleeding in high-risk patients with previous gastrointestinal diseases: a population-based case-control study.
Nørgård B; Pedersen L; Johnsen SP; Tarone RE; McLaughlin JK; Friis S; Sørensen HT
Aliment Pharmacol Ther; 2004 Apr; 19(7):817-25. PubMed ID: 15043523
[TBL] [Abstract][Full Text] [Related]
26. The risk of myocardial infarction in patients with reduced activity of cytochrome P450 2C9.
Visser LE; van Schaik RH; Jan Danser AH; Hofman A; Witteman JC; van Duijn CM; Uitterlinden AG; Pols HA; Stricker BH
Pharmacogenet Genomics; 2007 Jul; 17(7):473-9. PubMed ID: 17558303
[TBL] [Abstract][Full Text] [Related]
27. NSAID-related upper gastrointestinal bleeding: are risk factors considered during prophylaxis?
Dincer D; Duman A; Dikici H; Arici C; Suleymanlar I; Isitan F
Int J Clin Pract; 2006 May; 60(5):546-8. PubMed ID: 16700851
[TBL] [Abstract][Full Text] [Related]
28. Aspirin and other nonsteroidal anti-inflammatory drugs and risk of colorectal adenomatous polyps among endoscoped individuals.
Martínez ME; McPherson RS; Levin B; Annegers JF
Cancer Epidemiol Biomarkers Prev; 1995; 4(7):703-7. PubMed ID: 8672985
[TBL] [Abstract][Full Text] [Related]
29. Clinical study of upper gastrointestinal bleeding associated with low-dose aspirin in Japanese patients.
Okada K; Inamori M; Imajo K; Chiba H; Nonaka T; Shiba T; Sakaguchi T; Atsukawa K; Takahashi H; Hoshino E; Nakajima A
Hepatogastroenterology; 2009; 56(96):1665-9. PubMed ID: 20214214
[TBL] [Abstract][Full Text] [Related]
30. Risk of upper gastrointestinal hemorrhage in warfarin users treated with nonselective NSAIDs or COX-2 inhibitors.
Battistella M; Mamdami MM; Juurlink DN; Rabeneck L; Laupacis A
Arch Intern Med; 2005 Jan; 165(2):189-92. PubMed ID: 15668365
[TBL] [Abstract][Full Text] [Related]
31. [Significance of cytochrome P450 2C9 genotype for the bleeding complications in patients treated with acenocoumarol].
Márk L; Márki-Zay J; Fodor L; Kondacs A; Paragh G; Katona A
Orv Hetil; 2005 Apr; 146(16):739-43. PubMed ID: 15889670
[TBL] [Abstract][Full Text] [Related]
32. Impact of CYP2C9 genotype on pharmacokinetics: are all NSAIDs the same?
van Oijen MG; Laheij RJ
Gastroenterology; 2007 Dec; 133(6):2073-4; author reply 2074-5. PubMed ID: 18054587
[No Abstract] [Full Text] [Related]
33. Risks and benefits of COX-2 inhibitors vs non-selective NSAIDs: does their cardiovascular risk exceed their gastrointestinal benefit? A retrospective cohort study.
Rahme E; Nedjar H
Rheumatology (Oxford); 2007 Mar; 46(3):435-8. PubMed ID: 17255138
[TBL] [Abstract][Full Text] [Related]
34. [The duodenum and non-steroidal anti-inflammatory agents].
Pippa G; Apuzzo M; Bazuro ME; Tammaro G
Recenti Prog Med; 1990 Jun; 81(6):453-6. PubMed ID: 2251456
[TBL] [Abstract][Full Text] [Related]
35. Prospective study of acute gastrointestinal bleeding attributable to anti-inflammatory drug ingestion in the Yorkshire region of the United Kingdom.
Lim CH; Heatley RV
Postgrad Med J; 2005 Apr; 81(954):252-4. PubMed ID: 15811890
[TBL] [Abstract][Full Text] [Related]
36. Peptic ulcer and gastrointestinal hemorrhage associated with nonsteroidal anti-inflammatory drug use in patients younger than 65 years. A large health maintenance organization cohort study.
Lanza LL; Walker AM; Bortnichak EA; Dreyer NA
Arch Intern Med; 1995 Jul; 155(13):1371-7. PubMed ID: 7794085
[TBL] [Abstract][Full Text] [Related]
37. Non-steroidal anti-inflammatory drugs and gastrointestinal bleeding.
Lanas A
Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S37-42. PubMed ID: 10379468
[TBL] [Abstract][Full Text] [Related]
38. Proton-pump inhibitors reduce the risk of uncomplicated peptic ulcer in elderly either acute or chronic users of aspirin/non-steroidal anti-inflammatory drugs.
Pilotto A; Franceschi M; Leandro G; Paris F; Cascavilla L; Longo MG; Niro V; Andriulli A; Scarcelli C; Di Mario F
Aliment Pharmacol Ther; 2004 Nov; 20(10):1091-7. PubMed ID: 15569111
[TBL] [Abstract][Full Text] [Related]
39. Interactions between anti-ulcer drugs and non-steroidal anti-inflammatory drugs in cirrhotic patients with bleeding esophagogastric varices.
Yoshida H; Mamada Y; Taniai N; Mineta S; Kawano Y; Mizuguchi Y; Kakinuma D; Kanda T; Tajiri T
Hepatogastroenterology; 2009; 56(94-95):1366-70. PubMed ID: 19950793
[TBL] [Abstract][Full Text] [Related]
40. [Secondary and primary prophylaxis of gastropathy associated with nonsteroidal antiinflammatory drugs or low-dose-aspirin: a review based on four clinical scenarios].
Limmer S; Ittel TH; Wietholtz H
Z Gastroenterol; 2003 Aug; 41(8):719-28. PubMed ID: 12910426
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]